BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #3024Biotechnology
$9.54 −$0.83 (-8.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $9.90 +3.77%
Open$10.06
Prev close$10.37
Day range$9.40 – $10.58
Volume967.9K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$26.00+172.5% vs. price
  • Buy 100%
Low $22.00Now $9.54Avg $26.00High $30.00

Recent rating changes

The last 20 actions on file set price targets from $22.00 to $30.00, averaging $27.70.

DateFirmRatingTarget
13 Nov 2026 H.C. Wainwright BUY $30.00
2 Nov 2026 H.C. Wainwright BUY $30.00
30 Oct 2026 H.C. Wainwright BUY $30.00
29 Oct 2026 H.C. Wainwright BUY $30.00
15 Oct 2026 H.C. Wainwright BUY $30.00
14 Oct 2026 Piper Sandler BUY $26.00
14 Oct 2026 H.C. Wainwright BUY $30.00
5 Oct 2026 H.C. Wainwright BUY $30.00
2 Oct 2026 Piper Sandler BUY $26.00
9 Sep 2026 H.C. Wainwright BUY $30.00
8 Sep 2026 H.C. Wainwright BUY $30.00
28 Aug 2026 H.C. Wainwright BUY $30.00
17 Aug 2026 Morgan Stanley BUY $22.00
7 Aug 2026 Piper Sandler BUY $24.00
7 Aug 2026 H.C. Wainwright BUY $25.00
24 Jun 2026 Guggenheim BUY $30.00
15 Jun 2026 Guggenheim BUY $30.00
14 May 2026 Morgan Stanley BUY $22.00
8 May 2026 Piper Sandler BUY $24.00
8 May 2026 H.C. Wainwright BUY $25.00

Discussion

No comments yet — be the first to weigh in on GENB.

Sign in to join the discussion.

Scroll to Top